The Receipts

Individual trades that beat the S&P 500 by 15+ points and come with context: the member sat on a committee overseeing that industry, the trade landed days before market-moving news, the company receives federal program money, or the disclosure was filed late. Every line is a public fact. None of it is proof of wrongdoing — it's the paper trail.

16 receipts from 2025, strongest first. Repeat trades of the same stock by the same member are grouped.

Lisa McClain R-MI
Bought $RGTI · Jul 17, 2025 · $15,001 - $50,000
+222.5pts vs S&P
90 days
  • Disclosed 98 days after the buy — 53 days past the 45-day STOCK Act deadline
  • Filed as a spouse's trade
Tim Moore R-NC
Bought $TQQQ · Apr 22, 2025 · $15,001 - $50,000
+76.4pts vs S&P
90 days
  • Disclosed 52 days after the buy — 7 days past the 45-day STOCK Act deadline
  • +1 similar buy of $TQQQ also qualify
Tim Moore R-NC
Bought $TNA · Apr 8, 2025 · $15,001 - $50,000
+60.1pts vs S&P
90 days
  • Disclosed 66 days after the buy — 21 days past the 45-day STOCK Act deadline
  • +2 similar buys of $TNA also qualify
John Hickenlooper D-CO
Sold $LBRDA · May 19, 2025 · $500,001 - $1,000,000
+46.3pts vs S&P
90 days
  • Sits on the Senate Committee on Commerce, Science, and Transportation committee, which oversees an adjacent sector
  • Disclosed 351 days after the sale — 306 days past the 45-day STOCK Act deadline
  • Filed as a spouse's trade
Shri Thanedar D-MI
Sold $MSTR · Oct 21, 2025 · $15,001 - $50,000
+48.2pts vs S&P
90 days
  • Disclosed 296 days after the sale — 251 days past the 45-day STOCK Act deadline
Tommy Tuberville R-AL
Sold $AMGN · Apr 15, 2025 · $15,001 - $50,000
+15.1pts vs S&P
90 days
  • Sits on the Senate Committee on Health, Education, Labor, and Pensions committee, which oversees the health care sector
  • Disclosed 477 days after the sale — 432 days past the 45-day STOCK Act deadline
Tommy Tuberville R-AL
Sold $ORCL · Oct 7, 2025 · $15,001 - $50,000
+35.2pts vs S&P
90 days
  • Disclosed 302 days after the sale — 257 days past the 45-day STOCK Act deadline
Tim Moore R-NC
Bought $SMCY · Apr 17, 2025 · $15,001 - $50,000
+32.4pts vs S&P
90 days
  • Disclosed 57 days after the buy — 12 days past the 45-day STOCK Act deadline
  • +2 similar buys of $SMCY also qualify
Tommy Tuberville R-AL
Sold $OC · Oct 7, 2025 · $15,001 - $50,000
+16.8pts vs S&P
90 days
  • Sits on the Senate Committee on Armed Services committee, which oversees an adjacent sector
  • Disclosed 302 days after the sale — 257 days past the 45-day STOCK Act deadline
Tommy Tuberville R-AL
Sold $STZ · Apr 15, 2025 · $15,001 - $50,000
+26.6pts vs S&P
90 days
  • Disclosed 477 days after the sale — 432 days past the 45-day STOCK Act deadline
Sheri Biggs R-SC
Sold $MRK · Mar 19, 2025 · $15,001 - $50,000
+21.6pts vs S&P
90 days
  • Disclosed 200 days after the sale — 155 days past the 45-day STOCK Act deadline
  • Filed as a spouse's trade
Carol Miller R-WV
Sold $TGT · Mar 10, 2025 · $15,001 - $50,000
+20.8pts vs S&P
90 days
  • Disclosed 521 days after the sale — 476 days past the 45-day STOCK Act deadline
  • Filed as a spouse's trade
Tommy Tuberville R-AL
Sold $DUK · Apr 15, 2025 · $15,001 - $50,000
+17.8pts vs S&P
90 days
  • Disclosed 477 days after the sale — 432 days past the 45-day STOCK Act deadline
Gil Cisneros D-CA
Sold $RAL · Jul 8, 2025 · $15,001 - $50,000
+16.8pts vs S&P
90 days
  • Disclosed 66 days after the sale — 21 days past the 45-day STOCK Act deadline
Sheri Biggs R-SC
Sold $CVX · Mar 18, 2025 · $15,001 - $50,000
+15.8pts vs S&P
90 days
  • Disclosed 201 days after the sale — 156 days past the 45-day STOCK Act deadline
  • Filed as a spouse's trade
Carol Miller R-WV
Sold $PFE · Mar 10, 2025 · $15,001 - $50,000
+15.6pts vs S&P
90 days
  • Disclosed 521 days after the sale — 476 days past the 45-day STOCK Act deadline
  • Filed as a spouse's trade

How a Trade Becomes a Receipt

We score every disclosed trade against the S&P 500 over the same days (see methodology). A trade lands here when it's worth $15,000+ (range midpoint), beat the market by at least 15 points — a buy that outran SPY, or a sale followed by the stock lagging — and at least one of these is true: